About This Study
Myasthenia gravis (MG) is a rare disease that makes it hard for nerves and muscles to work together. The goal of this study is to compare two medicines, nipocalimab and efgartigimod, to see how well they work and how safe they are for people with this disease. The study will also look at how safe and helpful nipocalimab is for people who switch from efgartigimod.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Use of Study Health Plans
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 75 years old
- Female
- Male
Language
- This study enrolls English speakers only
Additional Study Information
- Compensation Offered
- Reimbursement offered
Study Locations
- Greater Winston-Salem, NC